🟢 Cresco Labs is trading 7% up today after Q2 revenue and adjusted EBITDA beat expectations

Cresco Labs is trading 7.14% up now at $0.78, as investors continue digesting the August 6, 2026 earnings release, which reported $173 million in revenue and $40 million in adjusted EBITDA, both ahead of expectations.

• No separate August 12, 2026 company announcement was identified.
• Management’s roughly flat Q3 revenue outlook and margin pressures remain counterweights.
• Broader markets are also modestly higher.